Diverse impacts of different rpoB mutations on the anti-tuberculosis efficacy of capreomycin
Funding for this study was provided by the National Key Research and Development Program of China (Grant no. 2021YFA1300901).
Authors
- Jifang Yu (ORCID: https://orcid.org/0000-0003-2446-6975)
- Yaokai Chen (ORCID: https://orcid.org/0000-0002-3229-0108)
- Jing Gu (ORCID: https://orcid.org/0000-0002-0291-3263)
- Jintian Xu (ORCID: https://orcid.org/0000-0001-9847-1617)
- Ke Li (ORCID: https://orcid.org/0009-0000-8949-7321)
- Tao Cheng (ORCID: https://orcid.org/0000-0002-4184-0730)
- Yi Lin (ORCID: https://orcid.org/0000-0003-4661-7199)
- Jiao-Yu Deng
Institutions
- Chinese Academy of Sciences (CN)
- Wuhan Institute of Virology (CN)
- Chongqing Public Health Medical Center (CN)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1016/j.ebiom.2025.105776
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Ministry of Science and Technology of the People's Republic of China
- National Key Research and Development Program of China